MRI scans to monitor glioblastoma after standard treatment
Part of Cancer clinical trials.
This study tests a new MRI scanning method to see if it can better monitor glioblastoma after standard treatment. It may help doctors detect tumor changes earlier and guide future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old.
- You have been diagnosed with glioblastoma and are about to start standard chemotherapy (temozolomide) after completing radiation therapy.
- You are able to lie still for MRI scans that last up to an hour.
- You are on a stable or decreasing dose of steroids for at least 5 days before starting the study.
- You have not had any previous treatment for glioblastoma other than surgery and chemoradiation, and you have not had radiation to the brain or chemotherapy for a lower-grade glioma before.
- You are not planning to use Tumor-Treating Fields, and you have no medical conditions or allergies that would make MRI unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether using advanced MRI scans before radiation therapy can help doctors target the tumor more precisely and possibly improve outcomes for people with glioblastoma. It aims to make radiation treatment more personalized.
This study tests how best to measure and track glioblastoma treatment while using MRI (a body scanner) to guide radiation. It may help improve how doctors assess the radiation response during therapy.
This study uses special MRI scans to measure oxygen levels in and around glioblastoma before and during radiation treatment. It may help researchers understand how oxygen affects treatment response and timing.
This study is testing a new way of using MRI scans to see which parts of a brain tumour are low on oxygen. This could help doctors target radiation therapy more precisely and improve treatment for people with fast-growing brain tumours.
This study tests whether a special MRI scan and a blood test can help predict how a specific type of brain tumor (malignant glioma) changes over time. It is for people starting standard radiation and chemotherapy on a special machine that combines MRI and radiation.
This study uses special MRI imaging with deuterium to see how radiotherapy affects newly diagnosed glioblastoma (GBM) with an IDH-wildtype tumor. It may help doctors better understand treatment response and timing, potentially improving how radiotherapy is planned.
Hear when a new Glioblastom WHO Grade 4 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.